Concepedia

Keita Sugiura

KS

Statistics

Publications

4

Citations

183

H-Index

4

Active since

2014

Affiliations

Kaken Pharmaceutical (Japan)(Current)

Bausch Health (United States)

Keita Sugiura is an author at Kaken Pharmaceutical (Japan) specializing in onychomycosis treatment, antifungal therapy, and antifungal agents.

Publications per year

2014–2021

4

Publications

4

The Low Keratin Affinity of Efinaconazole Contributes to Its Nail Penetration and Fungicidal Activity in Topical Onychomycosis Treatment

Keita Sugiura, Noriaki Sugimoto, Shinya Hosaka et al. · Antimicrobial Agents and Chemotherapy · 2014 · 91 citations · Full text

Medicine, Dermatology, Pharmacology +17

Efficacy Coefficients Determined Using Nail Permeability and Antifungal Activity in Keratin-Containing Media Are Useful for Predicting Clinical Efficacies of Topical Drugs for Onychomycosis

Yoshiki Matsuda, Keita Sugiura, Takashi Hashimoto et al. · PLoS ONE · 2016 · 58 citations · Full text

Medicine, Dermatology, Pharmacology +16

<i>In Vitro</i> and <i>In Vivo</i> Assessment of Dermatophyte Acquired Resistance to Efinaconazole, a Novel Triazole Antifungal

Atsushi Iwata, Yoko Watanabe, Naomichi Kumagai et al. · Antimicrobial Agents and Chemotherapy · 2014 · 19 citations · Full text

Medicine, Dermatology, Microbiology +17

In Vitro Combination Effect of Topical and Oral Anti-Onychomycosis Drugs on Trichophyton rubrum and Trichophyton interdigitale

Keita Sugiura, Akane Masumoto, Haruki Tachibana et al. · Journal of Fungi · 2021 · 15 citations · Full text

Medicine, Dermatology, Pharmacology +16

1–4 of 4